Review of Leishmaniasis Treatment: Can We See the Forest through the Trees?
There are three known clinical syndromes of leishmaniasis: cutaneous (CL), mucocutaneous (MCL), and visceral disease (VL). In MCL and VL, treatment must be systemic (either oral or intravenous), while CL treatment options vary and include observation-only localized/topical treatment, oral medication...
Main Authors: | Moshe Shmueli, Shalom Ben-Shimol |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/12/1/30 |
Similar Items
-
Unusual Observations in Leishmaniasis—An Overview
by: Priya Yadav, et al.
Published: (2023-02-01) -
Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
by: Sebastian Vernal, et al.
Published: (2019-04-01) -
Brief communication: Vitamin D serum levels in American tegumentary leishmaniasis from an endemic area in Northeast Brazil
by: Lorena Pinheiro Figueiredo, et al.
Published: (2023-01-01) -
Clinical, laboratory, and therapeutic characteristics of American tegumentary leishmaniasis in the 15 th State Health Division, Northwest Paraná State, Southern Brazil
by: Priscila Wolf Nassif, et al. -
Tegumentary leishmaniasis mimicking visceralization in a cirrhotic patient: atypical cutaneous lesions and local immunological features
by: Sebastian Vernal, et al.
Published: (2020-01-01)